Semaglutide use in people with obesity and type 2 diabetes from real-world utilization data: An analysis of the All of US Program. Mayer CS, Fontelo P. Diabetes Obes Metab 2024 Sep 9. doi: 10.1111/dom.15911.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mayer CS, Fontelo P. Semaglutide use in people with obesity and type 2 diabetes from real-world utilization data: An analysis of the All of US Program. Diabetes Obes Metab 2024 Sep 9. doi: 10.1111/dom.15911.
PMID: 39248157